http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101675501-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4743 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 |
| filingDate | 2011-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101675501-B1 |
| titleOfInvention | Combination of Clopidogrel and Aspirin |
| abstract | The present invention relates to a combination preparation comprising clopidogrel and aspirin, which comprises granules coated with a clopidogrel layer as an immediate-release layer and aspirin granules coated with an enteric layer in an encapsulated capsule. The present invention relates to a pharmaceutical composition for preventing clopidogrel and aspirin from physically interfering with each other to prevent eutectic phenomenon from occurring and prevent changes in formulation content, dissolution characteristics and bioequivalence in the short term, In addition, it has an effect of preventing the gastric wall injury by coating the aspirin with the enteric layer. |
| priorityDate | 2011-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.